SCHEMBL6818693

SCHEMBL6818693

CC(C)(C)OC(=O)c1cc(C#N)ccc1NC(=O)c1onc2ccc(S(=O)(=O)Cl)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 2/20 0.36
F10 P00742 1/20 0.33
DDR1 Q08345 1/20 0.32
PDE10A Q9Y233 1/20 0.32
ALDH1A1 P00352 2/20 0.31
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
FLT1 P17948 1/20 0.31
FLT4 P35916 1/20 0.31
KDR P35968 1/20 0.31
PDK1 Q15118 1/20 0.31
PDK2 Q15119 1/20 0.31
PDK3 Q15120 1/20 0.31
PDK4 Q16654 1/20 0.31
GPR6 P46095 1/20 0.31
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31
PDE4B Q07343 1/20 0.31
RXFP1 Q9HBX9 1/20 0.30
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6822703 0.87 ALB (0.48) ALBF10ALDH1A1LMNASMN1; SMN2
SCHEMBL6830643 0.86 ALB (0.36) ALBF10DDR1PDE10AALDH1A1
SCHEMBL7126301 0.86 PDE10A (0.34) ALBF10PDE10AALDH1A1PKM
SCHEMBL6818724 0.86 PDE10A (0.34) ALBF10PDE10AALDH1A1PDK1
SCHEMBL6818315 0.84 ALB (0.37) ALBALDH1A1AVPR2GPR27
SCHEMBL6818372 0.82 F10 (0.34) ALBF10PDE10AALDH1A1PDK1
SCHEMBL6818784 0.81 PDE10A (0.34) ALBF10PDE10AALDH1A1PDK1
SCHEMBL6819112 0.79 ABCB1 (0.33) F10PDE10AALDH1A1LMNARXFP1
SCHEMBL6814176 0.78 ALB (0.47) ALBF10PDE10AALDH1A1FLT1
SCHEMBL6821469 0.77 ALB (0.46) ALBF10ALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed